Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Ghasoub Rola, Maria Benkhadra, Laila Shafei, Sara Aldali, Layali Bakir, Anas Hamad, Saad Laws, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 5548.

https://doi.org/10.1182/blood-2025-5548

Published: 2025

Journal Articles

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2025-7264

Published: 2025

Journal Articles

Somatic mutations at diagnosis in patients with chronic Phase CML receiving frontline imatinib are associated with a higher rate of treatment failure: First analysis from the international CML foundation (iCMLf) genomics alliance on the harmony platform

Blood (2025) 146 (Supplement 1): 75.

https://doi.org/10.1182/blood-2025-75

Published: 2025

Journal Articles

Integrating oncofertility: Contraceptive guidance in chronic lymphocytic leukemia

Rafal Alshebly, Nabeel Qasem, Mohamed Yassin, Salem Al-Shammari, Khalil Al-Farsi

Blood (2025) 146 (Supplement 1): 7444.

https://doi.org/10.1182/blood-2025-7444

Published: 2025

Journal Articles

Impact of tyrosine kinase inhibitors on estimated glomerular filtration rate in chronic myeloid leukemia patients

Awni Alshurafa, Nabeel Qasem, Anas Babiker, Maria Benkhadra, Yousef Al-Asa'd, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 7306.

https://doi.org/10.1182/blood-2025-7306

Published: 2025

Journal Articles

Tonsillar hypertrophy as a rare presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma: A mini-review

Rafal Alshebly, Nabeel Qasem, Mohamed Yassin, Abdulrahman Al-Abdulmalek, Khalil Al-Farsi, Salem Al-Shammari

Blood (2025) 146 (Supplement 1): 7442.

https://doi.org/10.1182/blood-2025-7442

Published: 2025

Journal Articles

The use of eculizumab and tocilizumab in the treatment of hyperhemolysis syndrome, a literature review

Ali Aqel, Salam Al-Kindi, Jaafar Altouq, Abdullah Al Zayed, Mona alrasheed, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 6508.

https://doi.org/10.1182/blood-2025-6508

Published: 2025

Journal Articles

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Mohamed Yassin, Nirmish Shah, Andrew Campbell, Salam Al-Kindi, Wally Smith, Charles Jonassaint, Miguel Abboud, Raffaella Colombatti, Dipty Jain, Halima Bello-Manga, Mariane de Montalembert, Ana Silva-Pinto, Steven Okoli, Abdelaziz Fahem, Biree Andemariam

Blood (2025) 146 (Supplement 1): 1166.

https://doi.org/10.1182/blood-2025-1166

Published: 2025

Journal Articles

Budget impact analysis of rituximab biosimilar in patients with haematological cancers in Qatar

Laila Shafei, Amir Nounou, Mohamed Yassin, Anas Hamad

Blood (2025) 146 (Supplement 1): 7941.

https://doi.org/10.1182/blood-2025-7941

Published: 2025

Journal Articles

Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfo, Persefoni Talimtzi, Maria Angelopoulou, Tomas Arpas, Laura Ballotta, Leonidas Benetatos, Ana Margarida Bertolo, Horia Bumbea, Maurizio Cavallari, Anastasia Chatzidimitriou, Dominik Chraniuk, Anna Christoforidou, Francesca Cibien, Antonio Cuneo, Maria Ilaria del Principe, Marina Deodato, Enrico Derenzini, Michael Doubek, Fabiana Esposito, Lucia Farina, Gianmarco Favrin, Isacco Ferrarini, Annamaria Frustaci, Andrea Galitzia, Massimo Gentile, Iulia Roxana Iancu, Vanessa Innao, krzysztof jamroziak, Elzbieta Kalicinska, Maria Kislova, Ioannis Kyriakou, Luca Laurenti, Enrico Lista, Javier Loscertales, Alexandros Machairas, Giorgia Marcato, Francesca Martini, Nilla Maschio, Eva Minga, Riccardo Moia, Roberta Murru, Maura Nicolosi, Jacopo Olivieri, Carolina Pavlovsky, Miguel Pavlovsky, Sara Pepe, Ernesto Perez Persona, Giuseppe Petruzzellis, Gian Matteo Rigolin, Alessandro Sanna, Marina Siakantaris, Paolo Sportoletti, Oana Stanca, Niki Stavrogianni, Tamar Tadmor, Annamaria Tomasso, Marzia Varettoni, Theodoros Vassilakopoulos, Eva Gimeno Vazquez, Candida Vitale, Mohamed Yassin, Mihnea Zdrenghea, Klaudia Zielonka, Livio Trentin, Kostas Stamatopoulos, Paolo Ghia

Blood (2025) 146 (Supplement 1): 6287.

https://doi.org/10.1182/blood-2025-6287

Published: 2025

Journal Articles

An updated systematic review and meta-analysis of caplacizumab for immune thromboticthrombocytopenic purpura: Insights into efficacy and safety

Mohamed Yassin, Ghasoub Rola, Nada Takhtinejad, Anas Babiker, Lulwah Altourah, Mona alrasheed

Blood (2025) 146 (Supplement 1): 3102.

https://doi.org/10.1182/blood-2025-3102

Published: 2025

Journal Articles

Asciminib and pregnancy in CML: Preliminary human data and clinical implications from 47 reported outcomes

Elisabetta Abruzzese, Ekaterina Chelysheva, Delphine Rea, Katia Pagnano, Mohamed Yassin, Nithya Agrawal, Malgorzata Trawinska, Anna Turkina, Jane Apperley, Paolo De Fabritiis

Blood (2025) 146 (Supplement 1): 5566.

https://doi.org/10.1182/blood-2025-5566

Published: 2025

Journal Articles

Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar

Mohamed Ismail, BS, MSc, Marzia Vezzalini, Ali Al Sayab, Maria Monne, Vinod Gupta, Govundarajulu Varadharaj, Mohamed Alsharshani, Mohamed Yassin, Claudio Sorio, MD PhD, Helmout Modjtahedi, Nader I. Al-Dewik, PhD

Blood (2018) 132 (Supplement 1): 5124.

https://doi.org/10.1182/blood-2018-99-113482

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Somatic mutations at diagnosis in patients with chronic Phase CML receiving frontline imatinib are associated with a higher rate of treatment failure: First analysis from the international CML foundation (iCMLf) genomics alliance on the harmony platform

Integrating oncofertility: Contraceptive guidance in chronic lymphocytic leukemia

Impact of tyrosine kinase inhibitors on estimated glomerular filtration rate in chronic myeloid leukemia patients

Tonsillar hypertrophy as a rare presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma: A mini-review

The use of eculizumab and tocilizumab in the treatment of hyperhemolysis syndrome, a literature review

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Budget impact analysis of rituximab biosimilar in patients with haematological cancers in Qatar

Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study

An updated systematic review and meta-analysis of caplacizumab for immune thromboticthrombocytopenic purpura: Insights into efficacy and safety

Asciminib and pregnancy in CML: Preliminary human data and clinical implications from 47 reported outcomes

Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only